| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 127,031 | 131,813 | 162,690 | 114,563 | | Cost of Revenue | 57,776 | 60,950 | 76,274 | 55,602 | | | Gross Profit | 69,255 | 70,863 | 86,416 | 58,961 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 52,977 | 56,745 | 69,044 | 47,806 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 3,002 | 2,719 | 2,664 | 2,338 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 13,276 | 11,399 | 14,708 | 8,817 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 4,149 | (3,719) | (91) | (7,836) | | Earnings Before Interest And Taxes | 13,411 | 8,070 | 14,227 | 981 | | Interest Expense | (94) | 46 | 48 |
-
| | Income Before Tax | 13,505 | 8,024 | 14,179 | 981 | | Income Tax Expense | 4,994 | (777) | 5,332 | 4,338 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 8,511 | 8,801 | 8,847 | (3,357) | | | Non-recurring Events | | Discontinued Operations | (60) | (22) | (5) | 28 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 8,451 | 8,779 | 8,842 | (3,329) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $8,451 | $8,779 | $8,842 | ($3,329) |
|
1.52% Nasdaq 0.00%
Income Statement
